Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure

NCT04311697 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

203

Enrollment

OTHER

Sponsor class

Conditions

Critical COVID-19 With Respiratory Failure
Acute Respiratory Distress Syndrome (ARDS)
Corona Virus Infection
Acute Lung Injury

Interventions

DRUG: Aviptadil by intravenous infusion + standard of care
DRUG: Normal Saline Infusion + standard of care

Sponsor

APR Applied Pharma Research s.a.